234 research outputs found
The association between serum copper and anaemia in the adult Second National Health and Nutrition Examination Survey (NHANES II) population
Though common in older adults, anaemia is unexplained in about one-third of cases. As a rare cause of anaemia and neutropenia, Cu deficiency could account for some cases of unexplained anaemia. We examined the relationship between serum Cu and unexplained anaemia among 11 240 participants in the Second National Health and Nutrition Examination Survey (NHANES II): 638 (5.7 % of all adults) were anaemic; 421 (3.7 %) were not explained by deficiencies of vitamin B12, folate or Fe, chronic illness or renal disease. Spline regression showed a U-shaped relationship between serum Cu levels and unexplained anaemia, indicating that both high and low serum Cu levels are associated with unexplained anaemia in adults. Chronic inflammation and mild Fe deficiency could account for the association between unexplained anaemia and elevated Cu levels. On the other hand, the finding of hypocupraemia in a subset of adults with unexplained anaemia suggests that Cu deficiency may be a common reversible cause of anaemia in adults
Initial Assessment of Variability of Responses to Toxicants in Donor-Specific Endothelial Colony Forming Cells
There is increased interest in using high throughput in vitro assays to characterize human population variability in response to toxicants and drugs. Utilizing primary human endothelial colony-forming cells (ECFCs) isolated from blood would be highly useful for this purpose because these cells are involved in neonatal and adult vasculogenesis. We characterized the cytotoxicity of four known toxic chemicals (NaAsO2, CdCl2, tributyltin [TBT], and menadione) and their four relatively nontoxic counterparts (Na2HAsO4, ZnCl2, SnCl2, and phytonadione, respectively) in eight ECFC clones representing four neonatal donors (2 male and 2 female donors, 2 clones per donor). ECFCs were exposed to 9 concentrations of each chemical in duplicate; cell viability was evaluated 48 h later using the fluorescent vital dye fluorescent dye 5-Carboxyfluorescein Diacetate (CFDA), yielding concentration-effect curves from each experiment. Technical (day-to-day) variability of the assay, assessed from three independent experiments, was low: p-values for the differences of results were 0.74 and 0.64 for the comparison of day 2 vs. day 1 and day 3 vs. day 1, respectively. The statistical analysis used to compare the entire concentration-effect curves has revealed significant differences in levels of cytotoxicity induced by the toxic and relatively nontoxic chemical counterparts, demonstrating that donor-specific ECFCs can clearly differentiate between these two groups of chemicals. Partitioning of the total variance in the nested design assessed the contributions of between-clone and between-donor variability for different levels of cytotoxicity. Individual ECFC clones demonstrated highly reproducible responses to the chemicals. The most toxic chemical was TBT, followed by NaAsO2, CdCl2, and Menadione. Nontoxic counterparts exhibited low cytotoxicity at the higher end of concentration ranges tested. Low variability was observed between ECFC clones obtained from the same donor or different donors for CdCl2, NaAsO2, and TBT, but for menadione, the between-donor variability was much greater than the between-clone variability. The low between-clone variability indicates that an ECFC clone may represent an individual donor in cell-based assays, although this finding must be confirmed using a larger number of donors. Such confirmation would demonstrate that an in vitro ECFC-based testing platform can be used to characterize the inter-individual variability of neonatal ECFCs exposed to drugs and/or environmental toxicants
A genome-wide association study identifies protein quantitative trait loci (pQTLs)
There is considerable evidence that human genetic variation influences gene expression. Genome-wide studies have revealed that mRNA levels are associated with genetic variation in or close to the gene coding for those mRNA transcripts - cis effects, and elsewhere in the genome - trans effects. The role of genetic variation in determining protein levels has not been systematically assessed. Using a genome-wide association approach we show that common genetic variation influences levels of clinically relevant proteins in human serum and plasma. We evaluated the role of 496,032 polymorphisms on levels of 42 proteins measured in 1200 fasting individuals from the population based InCHIANTI study. Proteins included insulin, several interleukins, adipokines, chemokines, and liver function markers that are implicated in many common diseases including metabolic, inflammatory, and infectious conditions. We identified eight Cis effects, including variants in or near the IL6R (p = 1.8Ă10 -57), CCL4L1 (p = 3.9Ă10-21), IL18 (p = 6.8Ă10-13), LPA (p = 4.4Ă10-10), GGT1 (p = 1.5Ă10-7), SHBG (p = 3.1Ă10-7), CRP (p = 6.4Ă10-6) and IL1RN (p = 7.3Ă10-6) genes, all associated with their respective protein products with effect sizes ranging from 0.19 to 0.69 standard deviations per allele. Mechanisms implicated include altered rates of cleavage of bound to unbound soluble receptor (IL6R), altered secretion rates of different sized proteins (LPA), variation in gene copy number (CCL4L1) and altered transcription (GGT1). We identified one novel trans effect that was an association between ABO blood group and tumour necrosis factor alpha (TNF-alpha) levels (p = 6.8Ă10-40), but this finding was not present when TNF-alpha was measured using a different assay , or in a second study, suggesting an assay-specific association. Our results show that protein levels share some of the features of the genetics of gene expression. These include the presence of strong genetic effects in cis locations. The identification of protein quantitative trait loci (pQTLs) may be a powerful complementary method of improving our understanding of disease pathways. Š 2008 Melzer et al
ĐĐĐĐŚĐĐĐĐĐŤĐ Đ ĐĐĐĐĐĐĄĐĐĐ ĐĐĐĐĐТĐĐĐ Đ ĐĄĐЧĐĐĐĐĐĐРТУĐĐĐĐ-ĐĐĐĐĐĐĐŹĐĄĐĐĐĐ ĐĐĐĄĐĄĐĐĐ Đ ĐĄĐĐĐĐ ĐĄĐĐĐĐ ĐĐ ĐТĐĐĐ: ĐĐĐŠĐĐ ĐĐĐĐĐĐĐĐТ ĐĐĐТĐĐĐĐŤĐĽ ĐХТĐЧĐĐĐĐĐ Đ ĐĐĐ ĐĐ ĐĐĐĄĐĽĐĐĐĐĐĐĐ
Devonian dikes of the Urik-Belaya and Shagayte-Gol-Urik zones and Miocene lavas of the Urik volcanic field are spatially associated with each other at the structural junction between the Neoproterozoic Tuva-Mongolian massif and Siberian craton. The former dike belt is represented by basalts and basaltic andesites of tholeiitic series and the latter one by trachybasalts, trachyandesitic basalts of moderately alkaline series and trachybasalts, phonotephrites of highly alkaline one. The Urik volcanic field is composed of trachybasalts and trachyandesitic basalts of moderately alkaline series. A partial similarity between magmatic series of different age is found in terms of major oxides, trace elements, and Sr, Pb isotopes. The common component corrected for age was defined through its converging mixing trends with those of the lithospheric mantle and crust. The component identification was a basis for deciphering the nature of isotopic and geochemical heterogeneity of evolved magmatic sources. It was inferred that the common component characterizes either a modified (depleted) reservoir of the lower mantle or, more likely, a local region of the convecting asthenospheric mantle that underlies the Tuva-Mongolian massif. The latter interpretation assumes the formation of a locally convecting asthenosphere in the middle Neoproterozoic, along with the development of the Oka zone at the massif, and puts constrains on later sufficient processing of the asthenosphere due to rising plumes or subducting slabs.Đ ŃŃŃŃĐşŃŃŃнОП ŃĐžŃНононии ноОпŃĐžŃĐľŃОСОКŃкОгО ТŃвинО-ĐОнгОНŃŃкОгО ПаŃŃива Ń ĐĄĐ¸ĐąĐ¸ŃŃкиП ĐşŃĐ°ŃОнОП ĐżŃĐžŃŃŃĐ°Đ˝ŃŃвоннО ŃОвПоŃĐľĐ˝Ń ĐźĐľĐśĐ´Ń ŃОйОК довОнŃкио даКки ĐŁŃик-ĐоНŃŃкОгО и ШагаКŃŃ-ĐОН-ĐŁŃикŃкОгО пОŃŃОв и ПиОŃонОвŃĐľ ĐťĐ°Đ˛Ń ĐŁŃикŃкОгО вŃНканиŃĐľŃкОгО пОНŃ. ĐĐľŃвŃĐš даКкОвŃĐš пОŃŃ ĐżŃодŃŃавНон йаСаНŃŃаПи-андоСийаСаНŃŃаПи ŃОНоиŃОвОК ŃĐľŃии, вŃĐžŃОК â ŃŃĐ°Ń
ийаСаНŃŃаПи-ŃŃĐ°Ń
иандоСийаСаНŃŃаПи ŃПоŃоннОŃоНОŃнОК ŃĐľŃии Ń ĐťĐžĐşĐ°ĐťŃĐ˝ŃП ŃĐ°ŃĐżŃĐžŃŃŃанониоП ŃŃĐ°Ń
ийаСаНŃŃОв-ŃОнОŃĐľŃŃиŃОв ŃĐľŃии пОвŃŃоннОК ŃоНОŃнОŃŃи. ĐŁŃикŃкОо вŃНканиŃĐľŃкОо пОНо ОйŃаСŃŃŃ ŃŃĐ°Ń
ийаСаНŃŃŃ-ŃŃĐ°Ń
иандоСийаСаНŃŃŃ ŃПоŃоннОŃоНОŃнОК ŃĐľŃии. ĐŃŃвНонО ŃĐ°ŃŃиŃнОо ŃŃ
ОдŃŃвО кОнŃонŃŃĐ°ŃиК поŃŃОгоннŃŃ
ОкŃидОв, ПикŃĐžŃНоПонŃОв и иСОŃОпнŃŃ
ĐžŃнОŃониК ŃŃŃОнŃĐ¸Ń Đ¸ ŃвинŃĐ° ŃаСнОвОСŃĐ°ŃŃĐ˝ŃŃ
ПагПаŃиŃĐľŃкиŃ
ŃĐľŃиК. ĐĄ пОпŃавкОК на вОСŃĐ°ŃŃ ĐžĐżŃодоНон ОйŃиК ĐşĐžĐźĐżĐžĐ˝ĐľĐ˝Ń ĐźĐ°ĐłĐźĐ°ŃиŃĐľŃкиŃ
ŃĐ°ŃпНавОв пО ŃŃ
ОдŃŃиПŃŃ ŃŃондаП огО ŃПоŃĐľĐ˝Đ¸Ń Ń ĐşĐžĐźĐżĐžĐ˝ĐľĐ˝ŃаПи ПанŃиКнОК ŃĐ°ŃŃи НиŃĐžŃŃĐľŃŃ Đ¸ кОŃŃ. ĐдонŃиŃикаŃĐ¸Ń ĐşĐžĐźĐżĐžĐ˝ĐľĐ˝ŃĐ° пОŃĐťŃМиНа ĐžŃнОвОК Đ´ĐťŃ ŃĐ°ŃŃиŃŃОвки Ń
Đ°ŃĐ°ĐşŃĐľŃĐ° иСОŃОпнО-гоОŃ
иПиŃĐľŃкОК гоŃĐľŃОгоннОŃŃи ŃаСнОвОСŃĐ°ŃŃĐ˝ŃŃ
ПагПаŃиŃĐľŃкиŃ
иŃŃĐžŃникОв. ХдоНан вŃвОд Đž ŃОП, ŃŃĐž ОйŃиК ĐşĐžĐźĐżĐžĐ˝ĐľĐ˝Ń Ń
Đ°ŃĐ°ĐşŃĐľŃиСŃĐľŃ ĐťĐ¸ĐąĐž ПОдиŃиŃиŃОваннŃĐš (ОйодноннŃĐš) ниМноПанŃиКнŃĐš ŃоСоŃвŃĐ°Ń, НийО, ŃŃĐž йОНоо воŃĐžŃŃнО, НОкаНŃĐ˝ŃŃ ĐžĐąĐťĐ°ŃŃŃ ĐşĐžĐ˝Đ˛ĐľĐşŃиŃŃŃŃоК Đ°ŃŃонОŃŃĐľŃнОК ПанŃии, пОдŃŃиНаŃŃоК ТŃвинО-ĐОнгОНŃŃкиК ПаŃŃив. РпОŃНодноК инŃĐľŃĐżŃĐľŃĐ°Ńии дОпŃŃкаоŃŃŃ ĐžĐąŃаСОванио НОкаНŃнОгО кОнвокŃиŃŃŃŃогО ОйŃоПа Đ°ŃŃонОŃŃĐľŃŃ Đ˛ ŃĐľŃодино ноОпŃĐžŃĐľŃОСОŃ, ОднОвŃоПоннО Ń ĐˇĐ°ĐťĐžĐśĐľĐ˝Đ¸ĐľĐź и ŃаСвиŃиоП ĐкинŃкОК ĐˇĐžĐ˝Ń ĐźĐ°ŃŃива, и накНадŃваŃŃŃŃ ĐžĐłŃаниŃĐľĐ˝Đ¸Ń Đ˝Đ° пОŃНодŃŃŃио ŃŃŃĐľŃŃвоннŃĐľ ĐżŃоОйŃĐ°ĐˇĐžĐ˛Đ°Đ˝Đ¸Ń Đ°ŃŃонОŃŃĐľŃŃ ĐżĐžĐ´ вНиŃниоП пОднŃŃĐ¸Ń ĐżĐťŃПОвОгО иНи пОгŃŃĐśĐľĐ˝Đ¸Ń ŃĐťŃйОвОгО ПаŃĐľŃиаНа
Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma
<p>Abstract</p> <p>Background</p> <p>Malignant glioma is a rare cancer with poor survival. The influence of diet and antioxidant intake on glioma survival is not well understood. The current study examines the association between antioxidant intake and survival after glioma diagnosis.</p> <p>Methods</p> <p>Adult patients diagnosed with malignant glioma during 1991-1994 and 1997-2001 were enrolled in a population-based study. Diagnosis was confirmed by review of pathology specimens. A modified food-frequency questionnaire interview was completed by each glioma patient or a designated proxy. Intake of each food item was converted to grams consumed/day. From this nutrient database, 16 antioxidants, calcium, a total antioxidant index and 3 macronutrients were available for survival analysis. Cox regression estimated mortality hazard ratios associated with each nutrient and the antioxidant index adjusting for potential confounders. Nutrient values were categorized into tertiles. Models were stratified by histology (Grades II, III, and IV) and conducted for all (including proxy) subjects and for a subset of self-reported subjects.</p> <p>Results</p> <p>Geometric mean values for 11 fat-soluble and 6 water-soluble individual antioxidants, antioxidant index and 3 macronutrients were virtually the same when comparing all cases (n = 748) to self-reported cases only (n = 450). For patients diagnosed with Grade II and Grade III histology, moderate (915.8-2118.3 mcg) intake of fat-soluble lycopene was associated with poorer survival when compared to low intake (0.0-914.8 mcg), for self-reported cases only. High intake of vitamin E and moderate/high intake of secoisolariciresinol among Grade III patients indicated greater survival for all cases. In Grade IV patients, moderate/high intake of cryptoxanthin and high intake of secoisolariciresinol were associated with poorer survival among all cases. Among Grade II patients, moderate intake of water-soluble folate was associated with greater survival for all cases; high intake of vitamin C and genistein and the highest level of the antioxidant index were associated with poorer survival for all cases.</p> <p>Conclusions</p> <p>The associations observed in our study suggest that the influence of some antioxidants on survival following a diagnosis of malignant glioma are inconsistent and vary by histology group. Further research in a large sample of glioma patients is needed to confirm/refute our results.</p
Human Exposure to Selected Animal Neurocarcinogens: A Biomarker-Based Assessment and Implications for Brain Tumor Epidemiology
This review is based on the proceedings from the Second Lebow Conference held in Chicago in 2007. The conference concentrated on developing a framework for innovative studies in the epidemiology of environmental exposures, focusing specifically on the potential relationship with brain tumors. Researchers with different perspectives, including toxicology, pharmacokinetics, and epidemiological exposure assessment, exchanged information and ideas on the use of biomarkers of exposure in molecular epidemiology studies and summarized the current knowledge on methods and approaches for biomarker-based exposure assessment. This report presents the state of science regarding biomarker-based exposure assessment of the 4 most common neurocarcinogens: acrylamide, 1,3-butadiene, N-nitroso compounds, and polycyclic aromatic hydrocarbons. Importantly, these chemicals are also carcinogenic in other organs; therefore, this discussion is useful for environmental epidemiologists studying all cancer types
Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.
Background The etiological basis of glioma is poorly understood. We have used genetic markers in a Mendelian randomization (MR) framework to examine if lifestyle, cardiometabolic, and inflammatory factors influence the risk of glioma. This methodology reduces bias from confounding and is not affected by reverse causation.Methods We identified genetic instruments for 37 potentially modifiable risk factors and evaluated their association with glioma risk using data from a genome-wide association study of 12â488 glioma patients and 18â169 controls. We used the estimated odds ratio of glioma associated with each of the genetically defined traits to infer evidence for a causal relationship with the following exposures:Lifestyle and dietary factors-height, plasma insulin-like growth factor 1, blood carnitine, blood methionine, blood selenium, blood zinc, circulating adiponectin, circulating carotenoids, iron status, serum calcium, vitamins (A1, B12, B6, E, and 25-hydroxyvitamin D), fatty acid levels (monounsaturated, omega-3, and omega-6) and circulating fetuin-A;Cardiometabolic factors-birth weight, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, total triglycerides, basal metabolic rate, body fat percentage, body mass index, fasting glucose, fasting proinsulin, glycated hemoglobin levels, diastolic and systolic blood pressure, waist circumference, waist-to-hip ratio; andInflammatory factors- C-reactive protein, plasma interleukin-6 receptor subunit alpha and serum immunoglobulin E.Results After correction for the testing of multiple potential risk factors and excluding associations driven by one single nucleotide polymorphism, no significant association with glioma risk was observed (ie, PCorrected > 0.05).Conclusions This study did not provide evidence supporting any of the 37 factors examined as having a significant influence on glioma risk
Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Metabolic syndrome, a constellation of metabolic risk factors for type 2 diabetes and cardiovascular disease, is one of the fastest growing disease entities in the world. Weight loss is thought to be a key to improving all aspects of metabolic syndrome. Research studies have suggested benefits from diets rich in vegetables and fruits in helping individuals reach and achieve healthy weights.</p> <p>Objective</p> <p>To evaluate the effects of a ready to serve vegetable juice as part of a calorie-appropriate Dietary Approaches to Stop Hypertension (DASH) diet in an ethnically diverse population of people with Metabolic Syndrome on weight loss and their ability to meet vegetable intake recommendations, and on their clinical characteristics of metabolic syndrome (waist circumference, triglycerides, HDL, fasting blood glucose and blood pressure).</p> <p>A secondary goal was to examine the impact of the vegetable juice on associated parameters, including leptin, vascular adhesion markers, and markers of the oxidative defense system and of oxidative stress.</p> <p>Methods</p> <p>A prospective 12 week, 3 group (0, 8, or 16 fluid ounces of low sodium vegetable juice) parallel arm randomized controlled trial. Participants were requested to limit their calorie intake to 1600 kcals for women and 1800 kcals for men and were educated on the DASH diet. A total of 81 (22 men & 59 women) participants with Metabolic Syndrome were enrolled into the study. Dietary nutrient and vegetable intake, weight, height, leptin, metabolic syndrome clinical characteristics and related markers of endothelial and cardiovascular health were measured at baseline, 6-, and 12-weeks.</p> <p>Results</p> <p>There were significant group by time interactions when aggregating both groups consuming vegetable juice (8 or 16 fluid ounces daily). Those consuming juice lost more weight, consumed more Vitamin C, potassium, and dietary vegetables than individuals who were in the group that only received diet counseling (p < 0.05).</p> <p>Conclusion</p> <p>The incorporation of vegetable juice into the daily diet can be a simple and effective way to increase the number of daily vegetable servings. Data from this study also suggest the potential of using a low sodium vegetable juice in conjunction with a calorie restricted diet to aid in weight loss in overweight individuals with metabolic syndrome.</p
- âŚ